Evidence map›Paper›PMID 40872972›Full record

ArticleVaccines2025

Correction: Huang et al. The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6-35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial.

Lili Huang, Guangfu Li, Yuhui Zhang, Xue Zhao, Kai Wang, Chunyu Jia, Wei Zhang, Jiebing Tan, Xiaofen Chen, Qin Li and 7 more

Abstract readPublished Erratum
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Lili HuangHenan Provincial Centre for Disease Control and Prevention, Zhengzhou 450016, China.
Guangfu LiAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Yuhui ZhangAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Xue ZhaoAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Kai WangAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Chunyu JiaAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Wei ZhangHenan Provincial Centre for Disease Control and Prevention, Zhengzhou 450016, China.
Jiebing TanHenan Provincial Centre for Disease Control and Prevention, Zhengzhou 450016, China.
Xiaofen ChenAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Qin LiAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Hongyan JiangAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Rui AnAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Wenna LengAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Yongli YangDepartment of Epidemiology and Public Health, College of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Youcai AnAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.
Yanxia WangHenan Provincial Centre for Disease Control and Prevention, Zhengzhou 450016, China.
Yaodong ZhangAb&B Bio-Tech Co., Ltd. JS, Taizhou 225300, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors would like to make the following corrections to this published paper [...].

Identifiers

PMID40872972
PMCPMC12389928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.